Literature DB >> 8923430

Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy.

D R Braichotte1, J F Savary, P Monnier, H E van den Bergh.   

Abstract

BACKGROUND AND
OBJECTIVE: Under standardized conditions (drug and light dose, timing), the result of the photodynamic therapy (PDT) of carcinomas of the esophagus with tetra(meta-hydroxyphenyl)chlorin (mTHPC) shows large variations between patients. STUDY DESIGN/
MATERIALS AND METHODS: Before patients underwent PDT treatment, the mTHPC level was measured in the lesion, the normal surrounding tissue, and the oral cavity, with an apparatus based on fluorescence spectroscopy.
RESULTS: The fluctuations in degree of tumor destruction between patients can be explained by individual variations in the mTHPC level in the mucosa of the esophagus. The patients showing the highest mTHPC fluorescence signal had also the highest response to PDT. Also, a correlation between the mTHPC level in the oral cavity and esophagus mucosa has been found.
CONCLUSION: PDT can be improved by measuring the mTHPC level in the esophagus or the oral cavity before treatment by fluorescence spectroscopy, and then by adjusting the light dose to be applied to the observed mTHPC level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923430     DOI: 10.1002/(SICI)1096-9101(1996)19:3<340::AID-LSM10>3.0.CO;2-8

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  7 in total

1.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm.

Authors:  B C Wilson; M S Patterson; L Lilge
Journal:  Lasers Med Sci       Date:  1997-10       Impact factor: 3.161

2.  Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience.

Authors:  C Ell; L Gossner; A May; H T Schneider; E G Hahn; M Stolte; R Sroka
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

3.  Photophysical characterization and in vitro anti-leishmanial effect of 5,10,15,20-tetrakis(4-fluorophenyl) porphyrin and the metal (Zn(II), Sn(IV), Mn(III) and V(IV)) derivatives.

Authors:  Fabián Espitia-Almeida; Carlos Díaz-Uribe; William Vallejo; Doris Gómez-Camargo; Arnold R Romero Bohórquez; Ximena Zarate; Eduardo Schott
Journal:  Biometals       Date:  2022-01-07       Impact factor: 2.949

4.  Photodynamic Therapy for Barrett's Esophagus and Esophageal Carcinoma.

Authors:  Bashar J Qumseya; Waseem David; Herbert C Wolfsen
Journal:  Clin Endosc       Date:  2013-01-31

Review 5.  Photophysics and photochemistry of photodynamic therapy: fundamental aspects.

Authors:  K Plaetzer; B Krammer; J Berlanda; F Berr; T Kiesslich
Journal:  Lasers Med Sci       Date:  2008-02-05       Impact factor: 3.161

6.  Perturbative forward solver software for small localized fluorophores in tissue.

Authors:  F Martelli; S Del Bianco; P Di Ninni
Journal:  Biomed Opt Express       Date:  2011-12-02       Impact factor: 3.732

7.  Uptake and localisation of mTHPC (Foscan) and its 14C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study.

Authors:  S Andrejevic Blant; T M Glanzmann; J-P Ballini; G Wagnières; H van den Bergh; P Monnier
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.